Alnylam Pharmaceuticals
ALNY
#485
Rank
C$67.98 B
Marketcap
C$514.61
Share price
-6.87%
Change (1 day)
38.23%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company